Posts Tagged ‘Committee’

Physicians Committee for Responsible Medicine Diabetes Success Story


When doctors diagnosed John Beale with type 2 diabetes, he was determined to avoid diabetes medication. Find out how he did it. This Physicians Committee for Responsible Medicine reverse diabetes success story is based on Dr. Neal Barnards Program for Reversing Diabetes that is shown to be three times more effective than the American Diabetes Association dietary guidelines at controlling blood sugar.

A New Approach to Nutrition for Diabetes DVD by Physicians Committee for Responsible Medicine president Neal Barnard, MD


This DVD provides a guide to moving beyond simply managing diabetes. It will help you turn the disease around. It delivers medical results: weight loss, blood glucose control, and reduced heart disease risk, and may even reduce or prevent the need for some medications. This empowering program offers new hope and scientifically supported guidance from a caring team committed to your success.

American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep …

American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep …
DALLAS, July 14 /PRNewswire-USNewswire/ — After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs …

Avandia Put to Test By FDA Committee

Avandia Put to Test By FDA Committee
After years of controversy, the Food and Drug Administration is gearing up to decide the fate of popular diabetes drug, Avandia. An FDA advisory panel of experts will meet next week to weigh the evidence against Avandia and make a recommendation as to whether the GlaxoSmithKline drug poses cardiovascular risk to patients and should be pulled from the market. GlaxoSmithKline – Food and Drug …